A Prosthetic Advantage?

Scientists are analyzing how factors such as the length and stiffness of artificial limbs affect performance in athletes with amputations.

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

BLADE RUNNER: A pair of the prosthetic devices that Alena Grabowski tested in her University of Colorado Boulder labPATRICK CAMPBELL, UNIVERSITY OF COLORADO

Oscar Pistorius, a South African sprinter dubbed the “Blade Runner,” made history in 2012 when he became the first double amputee to participate in the Olympics, running the 400-meter dash. Pistorius had been barred from the 2008 competition by the International Association of Athletics Federations (IAAF) after researchers in Germany reported that his prosthetic limbs provided an advantage over the legs of an able-bodied athlete (Sport Technology, 1:220-27, 2008). However, the IAAF reversed its decision after a team of researchers in the U.S. conducted a follow-up study that incorporated several additional parameters and concluded that Pistorius’s artificial limbs, though mechanically different, were physiologically similar to biological ones (J Appl Physiol, 107:903-11, 2009).

Although the second study ultimately allowed Pistorius to compete in the Olympics, some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Diana Kwon

    Diana is a freelance science journalist who covers the life sciences, health, and academic life.

Published In

September 2017

Healing with Hallucinogens

The therapeutic benefits of psychedelic drugs

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide